How and Why Automated Medical Databases Should Be Used to Create Background Occurrences for Drug Outcomes and Safety Studies: Glaucoma in THIN (UK)

Oct-09

AUTHORS : Betina Blak (Details for study: CSD EPIC) now works at AstraZeneca, Horizon Place, 600 Capability Green, Luton, Bedfordshire LU1 3LU, UK – Email: betina.blak@astrazeneca.com

JOURNAL : Value in Health

REFERENCE: 12(7):A489

DOI : 10.1016/S1098-3015(10)75314-6

How and Why Automated Medical Databases Should Be Used to Create Background Occurrences for Drug Outcomes and Safety Studies: Glaucoma in THIN (UK)

More publications

Defining Mental Health Conditions Within Primary Care Data: A Validation Study With a Mixed Qualitative and Quantitative Approach

Characteristics and Outcomes of Over a Million Patients with Infammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource

Trends in clinical workload in UK primary care 2005–2019: a retrospective cohort study